← All medicines

Immune and inflammatory medicines

Marnetegragene autotemcel injection

Independent educational summary · Sources checked November 20, 2026

A cell-based gene therapy for leukocyte adhesion deficiency-I in eligible patients.

Profile scope: Marnetegragene autotemcel injection. Confirm the exact product and route; formulations and combination products are not interchangeable.

Possible side effects

Digestive symptoms, mouth soreness, hair loss, or skin darkening may occur.

Serious risks and warning signs

Serious infection, allergy, liver-related symptoms, or bleeding should prompt urgent assessment. The source warns about possible blood-cancer risk and specifies prolonged surveillance. Discuss the uncertainties and long-term monitoring plan with the treatment center.

A question for your healthcare team

What is my immediate infection-response plan, and how will long-term blood surveillance be maintained?

What to do with this information

Discuss persistent or troubling symptoms with your prescriber or pharmacist. For severe breathing difficulty, collapse, a seizure, or inability to wake someone, seek emergency help. Read the linked medicine information for drug-specific instructions, including situations requiring immediate action. For routine treatment changes, consult your prescriber rather than changing your dose on your own. Follow the urgent action instructions above and in the linked medicine information.

Sources

Sources checked November 20, 2026. An original AI-assisted educational summary, not a complete adverse-effect or interaction list. This profile is part of the broader library expansion, not the original prescription-use ranking. Inclusion does not confirm current product availability or mean that risks outweigh benefits. This page has not been independently reviewed by a clinician.